Happiness Biotech Group Ltd. (HAPP)

Income Statement (Annual)

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year	2020	2019	2018	2017	2016
Revenue	71.48	65.06	63.94	61.5	53
Revenue Growth (YoY)	9.87%	1.76%	3.97%	16.04%	-
Cost of Revenue	53.31	34.64	31.69	32.14	27.18
Gross Profit	18.18	30.42	32.25	29.35	25.82
Selling, General & Admin	14.99	12.66	8.24	7.25	6.96
Research & Development	1.66	2.36	2.16	1.86	1.66
Operating Expenses	16.65	15.02	10.4	9.11	8.61
Operating Income	1.53	15.4	21.84	20.24	17.21
Interest Expense / Income	0.11	0.1	0.08	0.13	0.49
Other Expense / Income	-0.33	-0.23	-0.15	-0.25	-0.31
Pretax Income	1.75	15.53	21.91	20.36	17.02
Income Tax	0.96	2.84	3.18	2.87	2.5
Net Income	0.79	12.69	18.72	17.49	14.52
Net Income Common	0.79	12.69	18.72	17.49	14.52
Net Income Growth	-93.80%	-32.23%	7.04%	20.49%	-
Shares Outstanding (Basic)	26	24	23	23	23
Shares Outstanding (Diluted)	26	24	23	23	23
Shares Change	9.71%	3.67%	-	-	-
EPS (Basic)	0.03	0.53	0.81	0.76	0.63
EPS (Diluted)	0.03	0.53	0.81	0.76	0.63
EPS Growth	-94.34%	-34.57%	6.58%	20.64%	-
Free Cash Flow Per Share	0.01	0.40	0.27	0.56	0.44
Dividend Per Share	0.015	-	-	-	-
Gross Margin	25.43%	46.75%	50.44%	47.73%	48.72%
Operating Margin	2.13%	23.67%	34.16%	32.91%	32.47%
Profit Margin	1.10%	19.50%	29.28%	28.44%	27.39%
Free Cash Flow Margin	0.17%	14.78%	9.80%	20.77%	19.28%
Effective Tax Rate	54.96%	18.31%	14.53%	14.10%	14.72%
EBITDA	2.74	16.32	22.69	20.63	17.66
EBITDA Margin	3.83%	25.09%	35.49%	33.55%	33.32%
Depreciation & Amortization	0.88	0.69	0.7	0.14	0.14
EBIT	1.86	15.63	21.99	20.49	17.51
EBIT Margin	2.60%	24.02%	34.39%	33.33%	33.05%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).